GlaxoSmithKline PLC ADR - 037733W10
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | History | Added to | 111,445 | 5,960 | 0.29% | 0.31% | 1 | +2,610 | 2.4% | Q2 2014 | Jul 30, 2014 |
| FCM INVESTMENTS/TX | History | Reduced | 31,410 | 1,680 | 0.77% | 0.71% | 2 | -700 | -2.18% | Q2 2014 | Jul 17, 2014 |
| BOYD WATTERSON ASSET MANAGEMENT LLC/OH | History | Reduced | 8,762 | 469 | 0.2% | 0.22% | 3 | -31 | -0.35% | Q2 2014 | Jul 15, 2014 |
| SpiderRock Trading LLC | History | Added to | 2,500 | 9 | 0.04% | 0.1% | 4 | +400 | 19.05% | Q2 2014 | Jul 07, 2014 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | History | Closed out | 0 | 0 | — | 2.17% | — | -6,717,451 | -100.0% | Q1 2014 | May 15, 2014 |